LONDON, October 28, 2014 /PRNewswire/ --

Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:

http://investor-edge.com/register

On Monday, shares in Zimmer Holdings Inc. traded between $104.72 and $105.90 before ending the session 0.29% lower at $104.98. The stock reported a trading volume of 0.57 million shares, much below its three months average volume of 1.26 million shares. Shares of the company traded at a PE ratio of 18.32. Zimmer Holdings Inc.'s shares have advanced 4.77% in the previous three trading sessions, 4.14% in the last three months and 12.65% on YTD basis. The company's stock is trading above its 50-day and 200-day moving averages of $101.33 and $99.27, respectively. Moreover, shares of Zimmer Holdings Inc. have a Relative Strength Index (RSI) of 61.67. Sign up and read the free notes on ZMH at:

www.Investor-Edge.com/ZMH-28Oct2014 [http://www.investor-edge.com/ZMH-28Oct2014 ]

Edwards Lifesciences Corp.'s stock edged 0.22% higher, to close the day at $117.02. The stock recorded a trading volume of 1.38 million shares, above its three months average volume of 1.03 million shares. The stock oscillated between $115.56 and $117.50 during the session. Over the last one month and over the past three months, Edwards Lifesciences Corp.'s shares have surged 13.89% and 37.67%, respectively. Further, the stock has rallied 77.95% since the start of this year. The company's stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $101.74 is above its 200-day moving average of $84.44. Additionally, Edwards Lifesciences Corp.'s stock traded at a PE ratio of 41.33 and has an RSI of 75.40. The complimentary notes on EW can be downloaded as in PDF format at:

www.Investor-Edge.com/EW-28Oct2014 [http://www.investor-edge.com/EW-28Oct2014 ]

On Monday, shares in Varian Medical Systems Inc. recorded a trading volume of 1.38 million shares, higher than its three months average volume of 0.72 million shares. The stock ended the day at $82.01, which was 1.57% above its previous day's closing of $80.74, and registered an intraday range of $80.73 and $82.02. Shares of the company traded at a PE ratio of 20.32. Varian Medical Systems Inc.'s shares have gained 1.26% in the previous three trading sessions, 1.37% in the last one month and 5.56% on YTD basis. The company's stock is trading below its 50-day and 200-day moving averages of $82.47 and $82.59, respectively. Furthermore, shares of Varian Medical Systems Inc. have an RSI of 49.48. Register for free on Investor-Edge and access the latest research on VAR at:

www.Investor-Edge.com/VAR-28Oct2014 [http://www.investor-edge.com/VAR-28Oct2014 ]

CareFusion Corp.'s stock edged 0.09% higher, to close Monday's session at $57.01, after oscillating between $56.88 and $57.06. The stock recorded a trading volume of 2.50 million shares, below its three months average volume of 2.95 million shares. Over the last one month and the previous three months, CareFusion Corp.'s shares have surged 24.64% and 27.20%, respectively. Additionally, from the beginning of 2014, the stock has gained an upside 43.17%. The company's stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $49.11 is above its 200-day moving average of $43.54. Further, CareFusion Corp.'s stock traded at a PE ratio of 26.67 and has an RSI of 79.32. The complete research on CFN is available for free at:

www.Investor-Edge.com/CFN-28Oct2014 [http://www.investor-edge.com/CFN-28Oct2014 ]

Baxter International Inc.'s stock finished Monday's session 0.03% higher at $69.85. A total of 1.54 million shares were traded, which was below its three months average volume of 2.39 million shares. The stock moved between $69.59 and $70.18 during the session. Although, Baxter International Inc.'s shares have lost 3.36% in the last one month, it has advanced 2.16% in the previous three trading sessions and 0.43% on YTD basis. The company's shares are trading below their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $72.61 is greater than its 200-day moving average of $72.34. Baxter International Inc.'s stock traded at a PE ratio of 14.52 and has an RSI of 45.50. Free in depth research on BAX is available at:

www.Investor-Edge.com/BAX-28Oct2014 [http://www.investor-edge.com/BAX-28Oct2014 ]

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge